Radius Health, Inc.

NasdaqGM:RDUS Stok Raporu

Piyasa değeri: US$480.8m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Radius Health Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

G. Martin

İcra Kurulu Başkanı

US$3.5m

Toplam tazminat

CEO maaş yüzdesi17.2%
CEO görev süresi2.3yrs
CEO sahipliğin/a
Yönetim ortalama görev süresiless than a year
Yönetim Kurulu ortalama görev süresi6.8yrs

Son yönetim güncellemeleri

Recent updates

Radius Recycling Stays In The Scrap Pile

Jul 16

Radius Recycling: An Attractive, But Volatile, Play On A Cleaner Future

Jun 03

Radius stock rises as elacestrant gets FDA priority review to treat breast cancer subtype

Aug 11

Reevaluating Radius Health

Feb 24

Radius Health EPS misses by $0.02, misses on revenue

May 07

When Will Radius Health, Inc. (NASDAQ:RDUS) Become Profitable?

Feb 23
When Will Radius Health, Inc. (NASDAQ:RDUS) Become Profitable?

Revisiting Radius Health

Feb 01

Radius Health acquires global rights to RAD011 in Prader-Willi syndrome

Jan 06

How Much Did Radius Health's(NASDAQ:RDUS) Shareholders Earn From Share Price Movements Over The Last Five Years?

Jan 01
How Much Did Radius Health's(NASDAQ:RDUS) Shareholders Earn From Share Price Movements Over The Last Five Years?

Radius Health on-track for record quarterly revenue for TYMLOS-SC

Dec 15

CEO Tazminat Analizi

G. Martin'un ücretlendirmesi Radius Health'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2022n/an/a

-US$69m

Mar 31 2022n/an/a

-US$73m

Dec 31 2021US$3mUS$600k

-US$70m

Sep 30 2021n/an/a

-US$76m

Jun 30 2021n/an/a

-US$60m

Mar 31 2021n/an/a

-US$87m

Dec 31 2020US$12mUS$413k

-US$109m

Tazminat ve Piyasa: G.'s total compensation ($USD3.49M) is above average for companies of similar size in the US market ($USD2.61M).

Tazminat ve Kazançlar: G.'s compensation has been consistent with company performance over the past year.

CEO

G. Martin (63 yo)

2.3yrs

Görev süresi

US$3,493,881

Tazminat

Mr. G. Kelly Martin has been Executive Chairman of Wren Therapeutics Ltd. since 2018. Mr. Martin serves as the Chief Executive Officer, President and Director at Radius Health, Inc. since April 28, 2020.H...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
G. Martin
CEO, President & Director2.3yrsUS$3.49mVeri yok
Danielle Holtschlag
VP of Sales & Head of U.S. Sales Channelsless than a yearUS$741.78kVeri yok
Chhaya Shah
Senior VP & Chief Business Officer2.2yrsUS$1.22m0.27%
$ 1.3m
Stavros Manolagas
Founder & Member of the Scientific Advisory Boardno dataVeri yokVeri yok
John Potts
Founder & Member of the Scientific Advisory Boardno dataVeri yokVeri yok
Michael Rosenblatt
Founderno dataVeri yokVeri yok
John Katzenellenbogen
Founder & Member of the Scientific Advisory Boardno dataVeri yokVeri yok
Mark Conley
VP, CFOless than a yearVeri yokVeri yok
Peter Schwartzman
Head of Corporate Financeno dataVeri yokVeri yok
Ethan Holdaway
Head of Investor Relationsless than a yearVeri yokVeri yok
Kim Clarke
General Counselless than a yearVeri yokVeri yok
Rohan Lathia
Head of Corporate & Business Developmentless than a yearVeri yokVeri yok

0.8yrs

Ortalama Görev Süresi

61.5yo

Ortalama Yaş

Deneyimli Yönetim: RDUS's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
G. Martin
CEO, President & Director2.3yrsUS$3.49mVeri yok
Stavros Manolagas
Founder & Member of the Scientific Advisory Boardno dataVeri yokVeri yok
John Potts
Founder & Member of the Scientific Advisory Boardno dataVeri yokVeri yok
Michael Rosenblatt
Founderno dataVeri yokVeri yok
John Katzenellenbogen
Founder & Member of the Scientific Advisory Boardno dataVeri yokVeri yok
Jean-Pierre Garnier
Independent Director6.7yrsUS$544.81k0.045%
$ 215.1k
Sean Murphy
Independent Director2yrsUS$534.84k0.012%
$ 55.5k
Willard Dere
Independent Director7.8yrsUS$536.69k0.037%
$ 178.7k
Cecil Richard Lyttle
Chairman of Scientific Advisory Board10.5yrsUS$30.00kVeri yok
Owen Hughes
Independent Chairman9.3yrsUS$832.23k0.034%
$ 163.1k
Catherine Friedman
Independent Director7yrsUS$556.41k0.045%
$ 215.1k
Gary Hattersley
Member of Scientific Advisory Board3.8yrsUS$1.94mVeri yok

6.8yrs

Ortalama Görev Süresi

68.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: RDUS's board of directors are considered experienced (6.8 years average tenure).